Craft

Acura Pharmaceuticals

Stock Price

$0

2024-10-29

Market Capitalization

$92.4 K

2024-10-29

Revenue

$1.6 M

FY, 2021

Acura Pharmaceuticals Summary

Company Summary

Overview
Acura Pharmaceuticals, a pharmaceutical company that develops antibiotics to treat bacterial infections. It offers Oxaydo tablets, a narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.
Type
Public
Status
Active
Founded
1935
HQ
Palatine, IL, US | view all locations
Website
http://acurapharm.com/
Cybersecurity rating
Sectors

Key People

  • Robert B. Jones, President, Chief Executive Officer and Board Member

    • Peter A. Clemens, Senior Vice President, Chief Financial Officer

      • Albert W. Brzeczko

        Albert W. Brzeczko, Vice President, Pharmaceutical Sciences

      Operating MetricsView all

      Warehouse Space, sq. ft.

      7K

      FY, 2020

      Patents Issued

      39
      2.6%

      Q3, 2021

      Administrative Space, sq. ft

      6K

      FY, 2020

      LocationsView all

      2 locations detected

      • Palatine, IL HQ

        United States

        616 N North Ct

      • Culver, IN

        United States

        16235 State Rd 17

      Acura Pharmaceuticals Financials

      Summary Financials

      Revenue (FY, 2021)
      $1.6M
      Net income (FY, 2021)
      ($879.0K)
      Cash (FY, 2021)
      $65.0K
      EBIT (FY, 2021)
      ($1.2M)
      Enterprise value
      $77.4K

      Footer menu